Utilization of robust CYP1A2 inhibitors should be discontinued ahead of initiating pirfenidone and prevented all through treatment method; if powerful CYP1A2 inhibitors are the one drug of choice, dosage reductions are advisedUtilization of potent CYP1A2 inhibitors should be discontinued in advance of initiating therapy and avoided throughout proce… Read More